Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03832907
Other study ID # IRB00107627
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 21, 2019
Est. completion date March 31, 2020

Study information

Verified date August 2021
Source Emory University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is an exploratory prospective study primary aiming to evaluate differences between Point-of-care (POC) testing (standard of care) and Dexcom G6 CGM (Continues Glucose Monitoring sensor system) in 1) glycemic control measured by mean daily blood glucose and 2) identifying hypoglycemic and hyperglycemic events - in patients with type 1 and type 2 diabetes treated with basal bolus insulin regimen.


Description:

Several studies have shown that the use of a device that can measure blood glucose levels every 5 minutes is more effective in identifying low blood glucose (hypoglycemia) and high blood glucose (hyperglycemia) when compared to regular measurements with fingersticks [point of care (POC)]. This is an exploratory prospective study primary aiming to evaluate differences between Point-of-care (POC) testing (standard of care) and Dexcom G6 CGM (Continues Glucose Monitoring sensor system) in 1) glycemic control measured by mean daily blood glucose and 2) identifying hypoglycemic and hyperglycemic events - in patients with type 1 and type 2 diabetes treated with basal bolus insulin regimen.


Recruitment information / eligibility

Status Completed
Enrollment 101
Est. completion date March 31, 2020
Est. primary completion date March 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. > 18 years admitted to a general medicine or surgical service. 2. Known history of T1D or T2D receiving insulin therapy 3. Subjects must have a randomization BG between 140 mg and 400 mg/dL without laboratory evidence of diabetic ketoacidosis (bicarbonate < 18 mEq/L, pH < 7.30, or positive serum or urinary ketones). 4. Patients with expected hospital length-of-stay of 3 or more days Exclusion Criteria: 1. Patients with acute illness admitted to the ICU or expected to require admission to the ICU. 2. Patients expected to require MRI procedures during hospitalization. 3. Mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study. 4. Female subjects who are pregnant or breast-feeding at time of enrollment into the study.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Dexcom G6 CGM - Continues Glucose Monitoring sensor system
A blinded factory-calibrated continues glucose monitoring sensor system Dexcom G6 will be placed shortly after admission. Two CGM devices will be inserted in all patients - one in the abdomen and one in the arm to also assess differences in blood glucose readings between upper extremity and abdominal insertion sites. Information on CGM readings will be collected daily during the hospital stay and after hospital discharge for 10 days using the Dexcom Studio software to download the Dexcom receiver data.
Diagnostic Test:
POC BG - Point-of-Care Blood Glucose monitoring
Standard of care - bedside point-of-care (POC) capillary blood glucose (BG) monitoring will be done before meals and bedtime daily during the hospital stay and after hospital discharge for 10 days.

Locations

Country Name City State
United States Emory University Atlanta Georgia

Sponsors (1)

Lead Sponsor Collaborator
Emory University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean Daily Blood Glucose by POC Reading ?ompared to CGM Reading Mean daily blood glucose will be calculated During hospital stay (3 days - up to 30 days)
Primary Number of Clinical Significant Hypoglycemia (<54 mg/dl) Events by POC Reading Compared to CGM Reading Number of clinical significant hypoglycemia (<54 mg/dl) events will be calculated During hospital stay (3 days - up to 30 days)
Primary Number of Severe Hyperglycemia (>240 mg/dl) Events by POC Reading Compared to CGM Reading Number of severe hyperglycemia (>240 mg/dl) events will be recorded During hospital stay (3 days - up to 30 days)
Secondary Mean Daily Blood Glucose by POC Reading Compared to CGM Reading Mean daily blood glucose will be calculated 10 days post discharge
Secondary Number of Clinical Significant Hypoglycemia (<54 mg/dl) Events by POC Reading Compared to CGM Reading Number of clinical significant hypoglycemia (<54 mg/dl) events will be calculated 10 days post discharge
Secondary Number of Clinical Significant Severe Hyperglycemia (>240 mg/dl) Events by POC Reading Compared to CGM Reading Number of severe hyperglycemia (>240 mg/dl) events will be recorded 10 days post discharge
Secondary Number of Nocturnal Hypoglycemic Events < 70 mg/dl (Between 22:00 and 06:00) by POC Reading Compared to CGM Reading Number of nocturnal hypoglycemic events < 70 mg/dl (between 22:00 and 06:00) will be recorded During hospital stay (3 days - up to 30 days)
Secondary Number of Nocturnal Hypoglycemic Events < 70 mg/dl (Between 22:00 and 06:00) by POC Reading Compared to CGM Reading Number of nocturnal hypoglycemic events < 70 mg/dl(between 22:00 and 06:00) will be recorded 10 days post discharge
Secondary Number of of Hypoglycemic Events < 70mg/dl in POC Group by POC Reading Compared to CGM Reading Number of of hypoglycemic events < 70mg/dl will be recorded During hospital stay (3 days - up to 30 days)
Secondary Number of Hypoglycemic Events < 70mg/dl by POC Reading Compared to CGM Reading Number of of hypoglycemic events < 70mg/dl will be recorded 10 days post discharge
Secondary Time in Hypoglycemia (Minutes) During the Day and Night by CGM Reading Time in hypoglycemia (minutes) during the day and night will be recorded. Only measured by CGM, Discrete POC values are not used to assess amount of time spent within a specific glucose range. . During hospital stay (3 days - up to 30 days)
Secondary Time in Hypoglycemia (Minutes) During the Day and Night by CGM Reading Time in hypoglycemia (minutes) during the day and night will be recorded. Only measured by CGM, Discrete POC values are not used to assess amount of time spent within a specific glucose range. . 10 days post discharge
Secondary Time in Hyperglycemia (Minutes) During the Day and Night> 240 mg/dl by CGM Reading Time in hyperglycemia (minutes) during the day and night> 240 mg/dl will be recorded. Only measured by CGM, Discrete POC values are not used to assess amount of time spent within a specific glucose range. . During hospital stay (3 days - up to 30 days)
Secondary Time in Hyperglycemia (Minutes) During the Day and Night> 240 mg/dl by CGM Reading Time in hyperglycemia (minutes) during the day and night> 240 mg/dl will be recorded. Only measured by CGM, Discrete POC values are not used to assess amount of time spent within a specific glucose range. 10 days post discharge
Secondary Number of Hyperglycemic Events > 240 mg/dl by POC Reading Compared to CGM Reading Number of hyperglycemic events > 240 mg/dl will be recorded During hospital stay (3 days - up to 30 days)
Secondary Number of Hyperglycemic Events > 240 mg/dl by POC Reading Compared to CGM Reading Number of hyperglycemic events > 240 mg/dl will be recorded 10 days post discharge
Secondary Percentage of BG Readings Within Target BG of 70 and 180 mg/dl by POC Reading Compared to CGM Reading Percentage of BG readings within target BG of 70 and 180 mg/dl will be calculated During hospital stay (3 days - up to 30 days)
Secondary Percentage of BG Readings Within Target BG of 70 and 180 mg/dl by POC Reading Compared to CGM Reading Percentage of BG readings within target BG of 70 and 180 mg/dl will be calculated 10 days post discharge
Secondary Percentage of Patients With Greater Than 5%-Time Below Glucose Target <70mg/dl by CGM Reading Percentage of patients with greater than 5%-time below glucose target <70mg/dl will be calculated. Only measured by CGM, Discrete POC values are not used to assess amount of time spent within a specific glucose range. During hospital stay (3 days - up to 30 days)
Secondary Percentage of Patients With Greater Than 5%-Time Below Glucose Target <70 mg/dl by CGM Reading Percentage of patients with greater than 5%-time below glucose target <70 mg/dl will be calculated 10 days post discharge
Secondary Percentage of Patients With Greater Than 5%-Time Above Glucose Target >180mg/dl by CGM Reading Percentage of patients with greater than 5%-time above glucose target >180 mg/dl will be calculated During hospital stay (3 days - up to 30 days)
Secondary Percentage of Patients With Greater Than 5%-Time Above Glucose Target >180 mg/dl by CGM Reading Percentage of patients with greater than 5%-time above glucose target >180 will be calculated 10 days post discharge
Secondary Glycemic Variability Calculated by Standard Deviation by CGM Reading Glycemic variability will be calculated using Standard Deviation During hospital stay (3 days - up to 30 days)
Secondary Glycemic Variability Calculated by MAGE by CGM Reading MAGE: average amplitude of glycemic excursions with values exceeding a certain threshold. 10 days post discharge
Secondary Number of Sensor Removal/Failures/Dislodgments Number of sensor removal/failures/dislodgments will be recorded During hospital stay (3 days - up to 30 days)
Secondary Mean Absolute Relative Difference (MARD) of CGM Compared to POC Accuracy of Dexcom G6 CGM, as defined by overall MARD, compared to POC During hospital stay (3 days - up to 30 days)
Secondary Percentage of Dexcom G6 CGM Sensor Values Within 30/30% for Values < 70 mg/d Compared to the Standard-of-care POC BG Percentage of CGM glucose values in the hypoglycemic range (<70 mg/dl) meeting %30/30 accuracy criteria. During hospital stay (3 days - up to 30 days)
Secondary Percentage of Values Within Zone A, B, C, D of the Clarke Error Grid Measured in Abdomen Percentage of CGM glucose values within defined performance zones (A-E) indicating potential for clinical error. The Clarke error grid analysis uses a Cartesian diagram, in which the estimated/predicted values are displayed on the y-axis, whereas the reference values are presented on the x-axis. This diagram is subdivided into 5 zones: A, B, C, D, and E. The points that fall within zones A and B represent, respectively, sufficiently accurate and acceptable glucose results (better outcome), points in zone C may prompt unnecessary corrections, points in zones D and E represent erroneous and incorrect treatment. During hospital stay (3 days - up to 30 days)
Secondary Percentage of Values Within Zone A, B, C of the Clarke Error Grid Measured in Arm Percentage of CGM glucose values within defined performance zones (A-E) indicating potential for clinical error. The Clarke error grid analysis uses a Cartesian diagram, in which the estimated/predicted values are displayed on the y-axis, whereas the reference values are presented on the x-axis. This diagram is subdivided into 5 zones: A, B, C, D, and E. The points that fall within zones A and B represent, respectively, sufficiently accurate and acceptable glucose results (better outcome), points in zone C may prompt unnecessary corrections, points in zones D and E represent erroneous and incorrect treatment. During hospital stay (3 days - up to 30 days) measured in arm
Secondary Number of Nocturnal Hypoglycemic Events < 54 mg/dl (Between 22:00 and 06:00) by POC Reading Compared to CGM Reading Number of nocturnal hypoglycemic events < 54 mg/dl (between 22:00 and 06:00) will be recorded During hospital stay (3 days - up to 30 days)
Secondary Number of Nocturnal Hypoglycemic Events < 54 mg/dl (Between 22:00 and 06:00) by POC Reading Compared to CGM Reading Number of nocturnal hypoglycemic events < 54 mg/dl(between 22:00 and 06:00) will be recorded 10 days post discharge
Secondary Number of of Hypoglycemic Events < 54 in POC Group by POC Reading Compared to CGM Reading Number of of hypoglycemic events < 54 will be recorded During hospital stay (3 days - up to 30 days)
Secondary Number of Hypoglycemic Events < 54mg/dl by POC Reading Compared to CGM Reading Number of of hypoglycemic events < 54mg/dl will be recorded 10 days post discharge
Secondary Percentage of Patients With Greater Than 5%-Time Below Glucose Target <54mg/dl by CGM Reading Percentage of patients with greater than 5%-time below glucose target <54mg/dl will be calculated. Only measured by CGM, Discrete POC values are not used to assess amount of time spent within a specific glucose range. During hospital stay (3 days - up to 30 days)
Secondary Percentage of Patients With Greater Than 5%-Time Above Glucose Target >240 mg/dl by CGM Reading Percentage of patients with greater than 5%-time above glucose target >240 will be calculated 10 days post discharge
Secondary Percentage of Patients With Greater Than 5%-Time Above Glucose Target >240 mg/dl by CGM Reading Percentage of patients with greater than 5%-time above glucose target >240 mg/dl will be calculated During hospital stay (3 days - up to 30 days)
Secondary Glycemic Variability Calculated by MAGE by CGM Reading The average amplitude of glycemic excursions with values exceeding a certain threshold. During hospital stay (3 days - up to 30 days)
Secondary Percentage of Patients With Greater Than 5%-Time Below Glucose Target <54 mg/dl by CGM Reading Percentage of patients with greater than 5%-time below glucose target <54 mg/dl will be calculated 10 days post discharge
Secondary Percentage of Dexcom G6 CGM Sensor Values Within 30/30% for Values 70-140 mg/dl Compared to the Standard-of-care POC BG Percentage of CGM glucose values within the 70-140 mg/dl range that meet %30/30 accuracy criteria. During hospital stay (3 days - up to 30 days)
Secondary Percentage of Dexcom G6 CGM Sensor Values Within 30/30% for Values 140-180 mg/dl , Compared to the Standard-of-care POC BG Percentage of CGM glucose values within the 140-180 mg/dl range that meet %30/30 accuracy criteria. During hospital stay (3 days - up to 30 days)
Secondary Percentage of Dexcom G6 CGM Sensor Values Within 30/30%for Values > 180 mg/dl, Compared to the Standard-of-care POC BG Percentage of CGM glucose values in the hyperglycemic range (>180 mg/dl) that meet %30/30 accuracy criteria. During hospital stay (3 days - up to 30 days)
Secondary Glycemic Variability Calculated by Standard Deviation by CGM Reading Glycemic variability will be calculated using Standard Deviation 10 days post discharge
Secondary Percentage of Dexcom G6 CGM Sensor Values Within 20/20% for Values < 70 mg/dl Compared to the Standard-of-care POC BG Percentage of CGM glucose values in the hypoglycemic range (<70 mg/dl) that meet %20/20 accuracy criteria. During hospital stay (3 days - up to 30 days)
Secondary Percentage of Dexcom G6 CGM Sensor Values Within 20/20% for Values 70-140 mg/dl Compared to the Standard-of-care POC BG Percentage of CGM glucose values within the 70-140 mg/dl range that meet %20/20 accuracy criteria. During hospital stay (3 days - up to 30 days)
Secondary Percentage of Dexcom G6 CGM Sensor Values Within 20/20%for Values > 180 mg/dl, Compared to the Standard-of-care POC BG Percentage of CGM glucose values in the hyperglycemic range (>180 mg/dl) that meet %20/20 accuracy criteria.. During hospital stay (3 days - up to 30 days)
Secondary Percentage of Dexcom G6 CGM Sensor Values Within 20/20% for Values 140-180 mg/dl , Compared to the Standard-of-care POC BG Percentage of CGM glucose values within the 140-180 mg/dl range that meet %20/20 accuracy criteria. During hospital stay (3 days - up to 30 days)
Secondary Percentage of Dexcom G6 CGM Sensor Values Within 15/15% for Values < 70 mg/dl Compared to the Standard-of-care POC BG Percentage of CGM glucose values in the hypoglycemic range (<70 mg/dl) that meet %15/15 accuracy criteria.. During hospital stay (3 days - up to 30 days)
Secondary Percentage of Dexcom G6 CGM Sensor Values Within 15/15% for Values 70-140 mg/dl Compared to the Standard-of-care POC BG Percentage of CGM glucose values within the 70-140 mg/dl range that meet %15/15 accuracy criteria. During hospital stay (3 days - up to 30 days)
Secondary Percentage of Dexcom G6 CGM Sensor Values Within 15/15% for Values 140-180 mg/dl , Compared to the Standard-of-care POC BG Percentage of CGM glucose values within the 140-180 mg/dl range that meet %15/15 accuracy criteria. During hospital stay (3 days - up to 30 days)
Secondary Percentage of Dexcom G6 CGM Sensor Values Within 15/15%for Values > 180 mg/dl, Compared to the Standard-of-care POC BG Percentage of CGM glucose values in the hyperglycemic range (>180 mg/dl) that meet %15/15 accuracy criteria. During hospital stay (3 days - up to 30 days)
See also
  Status Clinical Trial Phase
Completed NCT05594446 - Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
Completed NCT03975309 - DHS MIND Metabolomics
Completed NCT01855399 - Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes N/A
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Recruiting NCT04984226 - Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD Phase 2
Recruiting NCT05007990 - Caregiving Networks Across Disease Context and the Life Course
Active, not recruiting NCT04420936 - Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program N/A
Recruiting NCT03549559 - Imaging Histone Deacetylase in the Heart N/A
Completed NCT04903496 - Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
Completed NCT01437592 - Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects Phase 1
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT03390179 - Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Recruiting NCT05294822 - Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes N/A
Completed NCT04427982 - Dance and Diabetes/Prediabetes Self-Management N/A
Completed NCT02356848 - STEP UP to Avert Amputation in Diabetes N/A
Completed NCT03292185 - A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects Phase 1
Active, not recruiting NCT05477368 - Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes N/A
Completed NCT04496401 - PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus Phase 4